EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Validation of a COPD Patient-Reported Experience Measure (PREM-C9) in Ontario, Canada

Elaine Zibrowski, Floriana Islami, Alyson Kellar, Christopher Licskai, Madonna Ferrone, Shannon L. Sibbald

Patient Experience Journal · 29.04.2026 · 13 (1) · 218-228

DOI: 10.35680/2372-0247.2108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Patient Experience Journal, online erschienen am 29.04.2026. Verfasst von Elaine Zibrowski und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Patient-reported experience measures (PREM) are important tools for evaluating healthcare quality, yet their implementation in chronic obstructive pulmonary disease (COPD) care within Canada remains limited. Our objective was to examine the construct validity of the PREM-C9 instrument in a Canadian context and explore its potential clinical applications beyond measuring patient experience.

Methods

A two-phase, prospective, cross-sectional, mixed-methods study was conducted across 41 Best Care COPD sites in Ontario, Canada. In the quantitative phase, confirmatory factor analysis assessed the construct validity of the PREM-C9. In the qualitative phase, focus group interviews with COPD case managers explored implementation experiences and perceived clinical utility. Data collection occurred from November 2023 to February 2024.

Results

Confirmatory factor analysis supported the three-factor structure of the PREM-C9 with good internal consistency reliability (McDonald's Omega and Cronbach's alpha). The instrument demonstrated validity in the Canadian context with significant correlation between global healthcare ratings and total PREM scores. Case managers reported favorable perceptions of the assessment and described using patient responses to guide care actions, suggesting potential as a clinical conversation tool beyond its original purpose as an experience measure.

Conclusion

The PREM-C9 demonstrates construct validity within Canadian COPD care settings. Our adaptations, including terminology changes reflecting Canadian healthcare context and addition of a global healthcare rating item, enhanced its relevance. Further refinements addressing implementation challenges and scaling presentation could improve usability. The instrument shows promise as both a quality measurement tool and a communication aid that facilitates personalized care planning in integrated COPD management programs.

Zitieren

APA

Zibrowski, E., Islami, F., Kellar, A., Licskai, C., Ferrone, M., & Sibbald, S. L. (2026). Validation of a COPD Patient-Reported Experience Measure (PREM-C9) in Ontario, Canada. Patient Experience Journal, 13(1), 218-228. https://doi.org/10.35680/2372-0247.2108

Vancouver

Zibrowski E, Islami F, Kellar A, Licskai C, Ferrone M, Sibbald SL. Validation of a COPD Patient-Reported Experience Measure (PREM-C9) in Ontario, Canada. Patient Experience Journal. 2026;13(1):218-228. doi:10.35680/2372-0247.2108

BibTeX
@article{Zibrowski2026,
  author = {Zibrowski, Elaine and Islami, Floriana and Kellar, Alyson and Licskai, Christopher and Ferrone, Madonna and Sibbald, Shannon L.},
  title = {Validation of a COPD Patient-Reported Experience Measure (PREM-C9) in Ontario, Canada},
  journal = {Patient Experience Journal},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {218--228},
  doi = {10.35680/2372-0247.2108}
}
Kostenlos starten →